Latest Cost Reduction News

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Red Sky Energy reports steady cash flow from its Innamincka Dome projects and advances development at Killanoola, while securing a significant 35% stake in offshore Angola’s Block 6/24 with promising oil resource estimates.

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.

BirdDog Technology reported a slight 4.1% decline in Q3 FY25 sales to A$3.6 million while progressing strongly on its next-generation product roadmap and implementing significant cost reductions.

Burgundy Diamond Mines reported a pivotal Q1 2025, completing the transition to Point Lake open pit mining while securing US$73 million in diamond sales and advancing mine life extension plans to 2030 and beyond.

Coronado Global Resources delivered March quarter production in line with plans despite Queensland rainfall, progressing key expansion projects and implementing significant cost reductions to navigate challenging metallurgical coal markets.

DataWorks Group Limited has secured a two-year extension on its BetStop self-exclusion contract and is advancing its global RegTech pipeline, aiming for positive operating cash flow by December 2025.

Lincoln Minerals has launched a comprehensive re-assay program targeting historic drill core at its Minbrie Cu-Pb-Zn Project, alongside progressing graphite downstream test work and advancing its Green Iron Magnetite Project with strong industry interest.

Canadian Phosphate Limited reported a steady rise in Q1 sales to $534,000, driven by US demand, with a significant capacity expansion at a key customer set to boost Q2 performance. The company also advances exploration and permitting efforts amid shifting North American phosphate dynamics.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

Codrus Minerals advances its diversified exploration portfolio with permitting progress at Bull Run and promising uranium geochemical results at Jasper Wedge, while managing costs amid challenging gold markets.

Hiremii Limited has completed its 2024-25 AI recruitment platform roadmap nine weeks early, with its proprietary AI outperforming industry shortlisting benchmarks. Despite a slight revenue decline due to market slowdowns, the company is poised for growth through technology commercialization and strategic M&A.